Allergan, globally recognized for its Botox cosmetic injections, has revealed plans to eliminate more than 1,000 jobs across its operations. This move is part of a broader cost-cutting measure aimed at restructuring the company’s workforce in response to significant market challenges. The announcement was made through a filing with the U.S. Securities and Exchange Commission. […]
Teva Pharmaceutical Industries, the Israel-based generic drug manufacturer, has unveiled a drastic two-year restructuring plan aimed at rejuvenating its business and enhancing financial performance. The plan includes the elimination of 14,000 positions, representing over a quarter of its global workforce. This move is part of a broader strategy to reduce the company’s overall cost base […]